You have read all your free articles, to continue reading subscribe to read the rest of this content.
Venture capital company Nascent Invest has bought shares in Umeå-based QureTech Bio as part of a targeted new share issue. The multi-million SEK investment will provide long-term security for the Swedish life science company as it continues its work to discover and develop new solutions to combaAlready a subscriber Login…
Valo Therapeutics has successfully raised 11 million EUR in an oversubscribed Pre-IPO funding round. The Pre-IPO fund included participation from existing investors, Freeman Road, and new investors, including ASX-listed MMJ Group Holdings. The total raised to date is now over Euro 22 million (aroAlready a subscriber Login You have read…
The U.S. Biomedical Advanced Research and Development Authority (BARDA) have exercised another option under the ongoing contract for freeze-dried MVA-BN smallpox vaccine. The option, valued at USD 44 million, will cover qualification of the new fill-finish facility, currently being established atAlready a subscriber Login You have read all your free…
A first-of-its kind comparison of the business risks confronting six key European industries revealed that the biopharmaceutical sector faces the highest level of risk and economic uncertainty. The study conducted by Deloitte and commissioned by Janssen, compared six industry sectors: the biophAlready a subscriber Login You have read all your…
